Funding Status:
IPO
Industry:
End-to-End Drug Development
Estimated Revenue:
$1M to $10M
Technology:
Biopharma, Biotechnology, Health Care
Headquarters:
Loos, Nord-Pas-de-Calais, France
Total Funding:
77800000.0
Last Funding Date:
2016-11-01
Last Funding Type:
Post-IPO Equity
Employee Number:
101-250
Investors Number:
2.0
Founded Date:
1999-09-01